Workflow
Inspired Entertainment Builds on NJ Success with Launch of Caesars Palace Wheel of Wins™ in Michigan and Ontario
GlobeNewswire· 2025-06-05 12:30
**For downloadable high-res assets, click here** NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Inspired Entertainment, Inc. (“Inspired”) (NASDAQ: INSE), a leading provider of B2B gaming content, systems, and solutions, today announced additional launches of the exclusive Caesars Palace Wheel of Wins™, a revolutionary Hybrid Dealer® game developed for Caesars Entertainment’s marquee online casino platforms. Building on the successful performance in New Jersey, where the game has already launched, this produc ...
Dividend Harvesting Portfolio Week 222: $22,200 Allocated, $2,268.90 In Projected Dividends
Seeking Alpha· 2025-06-05 12:30
I am focused on growth and dividend income. My personal strategy revolves around setting myself up for an easy retirement by creating a portfolio which focuses on compounding dividend income and growth. Dividends are an intricate part of my strategy as I have structured my portfolio to have monthly dividend income which grows through dividend reinvestment and yearly increases. Feel free to reach out to me on Seeking AlphaAnalyst’s Disclosure:I/we have a beneficial long position in the shares of BP, MSTY, NN ...
ARLO SURPASSES $300M ANNUAL RECURRING REVENUE
Prnewswire· 2025-06-05 12:30
Arlo crosses key financial milestones and completes original five-year long range plan in just three yearsSAN JOSE, Calif., June 5, 2025 /PRNewswire/ -- Arlo Technologies, Inc. (NYSE: ARLO), a leading smart home security brand, announced today that it has now joined the ranks of elite public companies by surpassing $300M in annual recurring revenue (ARR), driven by continued growth from subscription services delivered by Arlo's AI-powered smart security platform.Joining the ranks of elite public companies w ...
AppLovin: S&P 500 Game Changer This Friday
Seeking Alpha· 2025-06-05 12:30
Now you can get access to the latest and highest-quality analysis of recent Wall Street buying and selling ideas with just one subscription to Beyond the Wall Investing ! There is a free trial and a special discount of 10% for you. Join us today!I initiated my coverage of AppLovin Corporation (NASDAQ: APP ) stock here on Seeking Alpha in mid-October last year with a "Hold" rating. Even as the stock kept growing, I thought that it should fall or grow outDaniel Sereda is chief investment analyst at a family o ...
Aftermath Silver Makes Early US$1.5-million Property Payment to EMX Royalty Corp for Berenguela Project Ag-Cu-Mn, Peru
Newsfile· 2025-06-05 12:30
Aftermath Silver Makes Early US$1.5-million Property Payment to EMX Royalty Corp for Berenguela Project Ag-Cu-Mn, PeruJune 05, 2025 8:30 AM EDT | Source: Aftermath Silver Ltd.Vancouver, British Columbia--(Newsfile Corp. - June 5, 2025) - Aftermath Silver Ltd. (TSXV: AAG) (OTCQX: AAGFF) (the "Company" or "Aftermath Silver") is pleased to provide an update on its Berenguela silver-copper-manganese project located in the Department of Puno, in southern central Peru (the "Project" or "Berenguela") ...
LED Lighting, EV Charging Station and Electrical Maintenance Solutions Provider Orion Hosts Q4 Conference Call Thursday, June 26th at 10am ET
GlobeNewswire· 2025-06-05 12:28
MANITOWOC, Wis., June 05, 2025 (GLOBE NEWSWIRE) -- Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electrical vehicle charging station, and maintenance services solutions, will host a conference call and webcast to review its fourth quarter and fiscal 2025 results on Thursday, June 26, 2025 at 10:00 a.m. ET. Orion will release results prior to the market’s opening that day. Webcast and Call DetailsDate / Time: Thursday, June 26th at 10:00 a.m. ETLive ...
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the 2025 European Hematology Association (EHA) Annual Meeting
GlobeNewswire· 2025-06-05 12:28
– Company to showcase preclinical studies of ARV-393, an investigational oral PROTAC BCL6 degrader, as a single agent in models of nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (AITL) and transformed follicular lymphoma, and in combination with small molecule inhibitors in models of diffuse large B-cell lymphoma – NEW HAVEN, Conn., June 05, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targete ...
Newmont's Record Free Cash Flow Sets the Pace: But Will It Last?
ZACKS· 2025-06-05 12:21
Key Takeaways NEM posted record Q1 free cash flow of $1.2B, up from an outflow of $74M in the prior-year period. Higher capex, tax payments, and asset sales are expected to dent Q2 free cash flow for Newmont. NEM's solid balance sheet supports long-term growth projects despite near-term cash flow pressure.Newmont Corporation (NEM) achieved a record first-quarter free cash flow of $1.2 billion, marking a significant turnaround from a negative $74 million in the same period a year ago. This substantial impr ...
NVIDIA Bullish on Auto Chip Business as Next Driver: Can It Deliver?
ZACKS· 2025-06-05 12:21
Key Takeaways NVDA's automotive revenue surged 72% YoY to $567M in Q1, targeting a multitrillion-dollar opportunity. NVIDIA's full-stack AI chips are now in production for Mercedes Benz, with Volvo and BYD also onboard. NVDA chips and robots are powering Tesla supercomputers and auto factories for GM and Hyundai.NVIDIA Corp. (NVDA) has identified a hidden gem for its highly demanded generative artificial intelligence (AI) enabled GPUs (graphical processing units) or chips. Aside from the robust business o ...
Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology
GlobeNewswire News Room· 2025-06-05 12:19
Landmark Peer-Reviewed Study Demonstrates Effectiveness of Personalized Dietary Therapy for IBS Patients Using inFoods® IBS Test.Gastroenterology, the premier journal in gastrointestinal science, features data supporting inFoods IBS as an effective personalized, non-drug approach for managing IBS.Study results suggest inFoods IBS could be particularly beneficial for IBS-M patients, a population with no current FDA-approved drug treatments. IRVINE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (N ...